You are here: HomeSolutionsIndustriesConsumer Health
print my pages

Country Report

Consumer Health in Mexico

Apr 2012

Price: US$2,400

About this Report

About this Report

Samples (FAQs about samples):

doc_pdf.png Sample Consumer Health Market Research Report

doc_excel_table.png Sample Consumer Health Data

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Consumer Health industry in Mexico with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Consumer Health industry in Mexico, our research will save you time and money while empowering you to make informed, profitable decisions.

When you purchase this report, you also get the data and the content from these category reports in Mexico for free:

The Consumer Health in Mexico market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth  
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Consumer Health in Mexico?
  • What are the major brands in Mexico?
  • What are the main trends in OTC Healthcare?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Sample Analysis

EXECUTIVE SUMMARY

Consumer health achieves highest growth since 2006

Despite the fragile economic situation of the county, consumer health grew 8% in current value terms in 2011 – the strongest growth since 2006. This performance was underpinned by demographic changes, as the population is rapidly ageing and the elderly consume more health products than their younger counterparts. Additionally, Mexico has the second-highest percentage of overweight and obese people in the world, which is increasing demand for weight loss products and products treating diseases caused by obesity, such as diabetes. Additionally, the government is making an effort to prevent chronic diseases caused by those conditions.

Weight management grows substantially

Mexico has the second-largest obese population in the world, and this has become an expensive epidemic for the health system in Mexico. As a result the government is increasingly sponsoring massive preventative health campaigns so that people are becoming increasingly aware of the problems caused by this condition, such as diabetes, which already accounts for around 14% of all deaths in the country, followed by cardiovascular diseases (11%) and hypertension (3%).Weight management products have taken advantage of this to promote their benefits. However, some of these are catalogued by the health authorities as “miracle products” – those which cannot scientifically prove their claims, and promise to be a definite and quick option to any health condition – which that have been outlawed for false advertising, causing some companies to be fined, some television advertisements to be withdrawn and some products to be banned completely.

Herbalife takes major step forward in 2011

Although Herbalife participates in only three healthcare categories (vitamins and dietary supplements, sports nutrition and herbal/traditional products) it is the largest player in the Mexican consumer health market and saw sales grow 33% over 2010-2011. The company benefits from the concept of nutrition clubs and a large direct sales force as its strategic driver. Through its highly successful nutrition clubs the company is able to offer an affordable means of consumption for lower-income consumers, with this segment accounting for the bulk of its customers.

Inexpensive medical consultation offices attract clients

Pharmacy chains with their small and inexpensive medical consultation offices continue to attract clients and generate the majority of all consumer health sales. Hypermarkets such as Soriana and Wal-Mart are benefiting from this practice, generating and increasing sales and consumer loyalty. Wal-Mart is taking a step further with a pilot test in a few stores, with external drugstores offerings free medical services between certain hours.

Government cracks down on “miracle” products

The government is becoming stricter in cracking down on “miracle products” that make unsubstantiated claims of benefits, particularly in the weight management and vitamins and dietary supplements categories. These products have been found to not only not deliver on their weight loss claims, but have had disastrous side effects as well. Many companies are being forced to pay fines and eliminate these products from their portfolio, resulting in decreasing sales and profits in select categories.

Table of Contents

Table of Contents

Consumer Health in Mexico - Industry Overview

EXECUTIVE SUMMARY

Consumer health achieves highest growth since 2006

Weight management grows substantially

Herbalife takes major step forward in 2011

Inexpensive medical consultation offices attract clients

Government cracks down on “miracle” products

KEY TRENDS AND DEVELOPMENTS

Genomma Lab Internacional SAB de CV innovates with flexible and fast business model, grows significantly

Antibiotics law reinforce reshapes the sales of medicines in the country

New demographic landscape shapes health legislation

Possible new regulations to favour international products

National health program very active during Calderon administration

MARKET INDICATORS

  • Table 1 Consumer Expenditure on Health Goods and Medical Services 2006-2011
  • Table 2 Life Expectancy at Birth 2006-2011

MARKET DATA

  • Table 3 Sales of Consumer Health by Category: Value 2006-2011
  • Table 4 Sales of Consumer Health by Category: % Value Growth 2006-2011
  • Table 5 Consumer Health Company Shares 2007-2011
  • Table 6 Consumer Health Brand Shares 2008-2011
  • Table 7 Sales of Consumer Health by Distribution Format: % Analysis 2006-2011
  • Table 8 Sales of Consumer Health by Category and Distribution Format: % Analysis 2011
  • Table 9 Forecast Sales of Consumer Health by Category: Value 2011-2016
  • Table 10 Forecast Sales of Consumer Health by Category: % Value Growth 2011-2016

APPENDIX

OTC registration and classification

Vitamins and dietary supplements’ registration and classification

Self-medication/self-care and preventative medicine

Switches

  • Summary 1 OTC Switches 2009-2011

DEFINITIONS

SOURCES

  • Summary 2 Research Sources

Consumer Health in Mexico - Company Profiles

Bayer de México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 5 Bayer de México SA de CV: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 6 Bayer de México SA de CV: Competitive Position 2011

Boehringer Ingelheim Promeco SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 9 Boehringer Ingelheim Promeco SA de CV: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 10 Boehringer Ingelheim Promeco SA de CV: Competitive Position 2011

Farmacias Similares SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 13 Farmacias Similares SA de CV: Competitive Position 2011

Genomma Lab Internacional SAB de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 16 Genomma Lab Internacional SAB de CV: Competitive Position 2011

GlaxoSmithKline México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 19 GlaxoSmithKline México SA de CV: Production Statistics 2010

COMPETITIVE POSITIONING

  • Summary 20 GlaxoSmithKline México SA de CV: Competitive Position 2011

Herbalife Internacional de México SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

COMPETITIVE POSITIONING

  • Summary 23 Herbalife Internacional de México SA de CV: Competitive Position 2011

Merck-México SA in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 26 Merck-México SA: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 27 Merck-México SA: Competitive Position 2011

Pfizer SA de CV in Consumer Health (Mexico)

STRATEGIC DIRECTION

KEY FACTS

COMPANY BACKGROUND

PRODUCTION

  • Summary 30 Pfizer SA de CV: Production Statistics 2011

COMPETITIVE POSITIONING

  • Summary 31 Pfizer SA de CV: Competitive Position 2011

Adult Mouth Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • Adult mouth care remains an extremely small category in Mexico, as dental care is not a priority for the majority of Mexicans. Mouth care products are generally purchased on the recommendation of a dentist, although the vast majority of Mexicans never go to a dentist. Dental products are considered expensive and consequently some people substitute them for natural remedies such as bicarbonate.

SWITCHES

COMPETITIVE LANDSCAPE

  • The competitive environment continued to be led by only three companies, which accounted for 91% of total retail sales in 2011. Laboratorios Sanfer SA de CV achieved a 41% value share due to its comprehensive product line, which includes the Kank-A and Kin brands, both of which offer not only OTC products to fight gingivitis but also toothpaste.

PROSPECTS

  • For the forecast period, adult mouth care is expected to see an overall CAGR of 4% to reach Mx$352 million by 2016. Sales of these products will not be able to support mass media education/awareness campaigns regarding the importance of adult mouth care. Laboratories will continue to allocate their advertising resources to products such as toothbrushes, toothpastes and, to a lesser extent, rinses. Efforts such as those by Oral-B which highlight the lack of mouth care culture among vast segments of the population are expected to be replicated by other companies wishing to increase their sales, but again the focus will be on their “common” products, not niche offerings such as adult oral care.

CATEGORY DATA

  • Table 11 Sales of Adult Mouth Care: Value 2006-2011
  • Table 12 Sales of Adult Mouth Care: % Value Growth 2006-2011
  • Table 13 Adult Mouth Care Company Shares by Value 2007-2011
  • Table 14 Adult Mouth Care Brand Shares by Value 2008-2011
  • Table 15 Forecast Sales of Adult Mouth Care: Value 2011-2016
  • Table 16 Forecast Sales of Adult Mouth Care: % Value Growth 2011-2016

Analgesics in Mexico - Category Analysis

HEADLINES

TRENDS

  • In 2011 the major players in the analgesics category turned to digital advertising in order to grow their share. The analgesics environment is relatively stable, with the majority of sales held by the largest and most established brands. As a result these brands sought to differentiate themselves in 2011, not only through extensive television advertising but also through social media, YouTube and company websites. This channel of advertising is becoming increasingly important as Internet penetration and social media usage increase in Mexico.

SWITCHES

COMPETITIVE LANDSCAPE

  • Bristol-Myers Squib led analgesic sales in 2011 with a 20% share and a value of Mx$815 million, driven by its Tempra acetaminophen brand. Despite an overall increase in sales (thanks to the overall growth of analgesics) Tempra has been losing share to Tylenol, which is more commonly recommended by paediatricians. Bayer was second with Mx$510 million in sales and a 13% value share, driven mostly by its Aspirina, Cafiaspirina, Cafiaspirina Forte and Aspirina Infantil brands. Bayer has been gaining share (sales increased 14% in 2011) through widespread marketing campaigns that include both television and online advertisements.

PROSPECTS

  • Prospects for OTC products in general and for analgesics in particular will be highly influenced by demographics in years to come. Mexico’s population, as in many emerging countries, is ageing; women passed from having many offspring to having only two children per woman within a couple of decades. This, combined with an increasing life expectancy, will create a larger group of people aged 60 and over, which will increase demand for more medications and health services. As inflammation and pain are common concerns among the elderly, analgesics are likely to experience strong growth over the forecast period and beyond. As birth rates are relatively low, child-specific analgesics are expected to continue to hold a small percentage of analgesics through the forecast period.

CATEGORY DATA

  • Table 17 Sales of Analgesics by Category: Value 2006-2011
  • Table 18 Sales of Analgesics by Category: % Value Growth 2006-2011
  • Table 19 Topical Analgesics/Anaesthetic by Format: % Value Breakdown 2006-2011
  • Table 20 Analgesics Company Shares by Value 2007-2011
  • Table 21 Analgesics Brand Shares by Value 2008-2011
  • Table 22 Forecast Sales of Analgesics by Category: Value 2011-2016
  • Table 23 Forecast Sales of Analgesics by Category: % Value Growth 2011-2016

Calming and Sleeping in Mexico - Category Analysis

HEADLINES

TRENDS

  • Dalay from Genomma Lab, which was launched in 2007, drives growth in this category. Genomma Lab is known to aggressively support its products in the mass media, allowing it to increase sales by up to 70%. In 2010 Genomma Lab was fined by COFEPRIS for showing misleading advertising, causing a drop of 28% in Dalay’s sales and a 15% drop in the overall calming and sleeping products category.

COMPETITIVE LANDSCAPE

  • Two major brands dominate the calming and sleeping category: Genomma Lab’s Dalay and Abbott Laboratorios’ Ivel, which together accounted for a 71% value share at the end of the review period. Their nearest competitors are GlaxoSmithKline’s Nytol and Bomuca’s Vivinox-n with value shares of 4% and 3% respectively. The remaining share of sales is very fragmented.

PROSPECTS

  • High levels of stress in large and mid-sized urban locations are boosting the need for calming and sleeping products. These are aggravated by economic and safety issues, both of which worsened over the review period. This situation could signal more opportunities for calming and sleeping products but it is highly likely that most new consumers will turn to herbal and natural products produced in an artisanal way instead of OTC medication.

CATEGORY DATA

  • Table 24 Sales of Calming and Sleeping: Value 2006-2011
  • Table 25 Sales of Calming and Sleeping: % Value Growth 2006-2011
  • Table 26 Calming and Sleeping Company Shares by Value 2007-2011
  • Table 27 Calming and Sleeping Brand Shares by Value 2008-2011
  • Table 28 Forecast Sales of Calming and Sleeping: Value 2011-2016
  • Table 29 Forecast Sales of Calming and Sleeping: % Value Growth 2011-2016

Cough, Cold and Allergy (Hay Fever) Remedies in Mexico - Category Analysis

HEADLINES

TRENDS

  • In response to issues with excessive self-medication that arose during the H1N1 outbreak, the Mexican authorities passed a law in 2010 banning sales of antibiotics without a prescription. This new legislation caused Mexicans who previously self-medicated with antibiotics to first try using OTC medication such as cough, could and allergy remedies to cure their illnesses (then if these products did not cure their symptoms they would go to a doctor to obtain a prescription for antibiotics). As a result, sales of cough, cold and allergy remedies grew rapidly in 2010 and 2011, with total sales rising almost Mx$1 billion over 2009-2011.

SWITCHES

COMPETITIVE LANDSCAPE

  • Halls from Cadbury Adams México S De RL De CV led the cough, cold and allergy remedies category at the end of the review period with 19% of value sales. It is interesting to note that Cadbury, a confectionery and snack company, leads this OTC category due to frequent consumption of medicated confectionery as candy. Mexicans consume medicated confectionery like sweets, with most hardly regarding such products as medicinal, consuming it with no signs of illness or discomfort. Halls’ medicated confectionery is extremely successful in the country, with sales worth Mx$1.7 billion in 2011 and dominating medicated confectionery with a 95% value share. Schering-Plough SA de CV was a distant second with 11% of total sales with Desenfriol, Afrin and Clarityne. The Vick range from Procter & Gamble de México SA de CV held just over 8% of cough, cold and allergy remedies’ value in 2011.

PROSPECTS

  • The cough, cold and allergy remedies category is expected to maintain high levels of growth as Mexican consumers continue to depend on these products as alternatives to antibiotics, which are no longer available without a prescription. Additionally, prospects for OTC products in general and for cold/flu remedies in particular will be highly influenced by demographics in coming years. As in many emerging countries, Mexico’s population is ageing; women passed from having many children to having only two children each within a couple of decades. This fact, combined with increasing life expectancy, will create a larger group of people aged 60 years and over, boosting demand for medications and health services.

CATEGORY DATA

  • Table 30 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 31 Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 32 Sales of Decongestants by Category: Value 2006-2011
  • Table 33 Sales of Decongestants by Category: % Value Growth 2006-2011
  • Table 34 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2006-2011
  • Table 35 Sales of Paediatric Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2006-2011
  • Table 36 Cough, Cold and Allergy (Hay Fever) Remedies Company Shares by Value 2007-2011
  • Table 37 Cough, Cold and Allergy (Hay Fever) Remedies Brand Shares by Value 2008-2011
  • Table 38 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: Value 2011-2016
  • Table 39 Forecast Sales of Cough, Cold and Allergy (Hay Fever) Remedies by Category: % Value Growth 2011-2016

Digestive Remedies in Mexico - Category Analysis

HEADLINES

TRENDS

  • Self-prescription is a widely extended practice in overall Mexican consumer health. There is practically no format (parapharmacies, chemists/pharmacies, large retailers, variety stores) that constitutes an exception to this practice. This situation is so pervasive that it was actually accepted as part of the normal pharmaceutical landscape of the country. However, with the severe outbreak of the H1N1 virus, by April and May of 2009 the situation had become a problem, as many infected people took a number of self-prescribed medications that masked the symptoms of the H1N1 virus, making it very difficult to correctly diagnose patients. After the H1N1 situation passed government health authorities warned about the recent appearance of “superbugs” that are resistant to penicillin and other antibiotics. This prompted the government to enforce the prescription law to sell antibiotics in August 2010. The enforcement of this law banned the sale of all antibiotics, including those treating digestive infections. As a result many Mexicans switched to OTC digestive remedies to cure their illnesses, going to a doctor to receive a prescription as a last resort, boosting sales of OTC digestive remedies, particularly diarrhoeal remedies.

SWITCHES

COMPETITIVE LANDSCAPE

  • Pisa Laboratorios SA with Electrolit, its diarrhoeal remedy, leads the digestive remedies category with 16% of retail value sales. Electrolit targets not only people with digestive discomfort, but is also marketed as a product that helps people to rehydrate due to sports, hot weather, etc.

PROSPECTS

  • Due to the restricted availability of antibiotics and the fact that Mexican food frequently causes digestive problems due to its spicy and greasy nature, digestive remedies are expected to perform well through the forecast period, growing at a CAGR of 3% in constant value terms.

CATEGORY DATA

  • Table 40 Sales of Digestive Remedies by Category: Value 2006-2011
  • Table 41 Sales of Digestive Remedies by Category: % Value Growth 2006-2011
  • Table 42 Digestive Remedies Company Shares by Value 2007-2011
  • Table 43 Digestive Remedies Brand Shares by Value 2008-2011
  • Table 44 Forecast Sales of Digestive Remedies by Category: Value 2011-2016
  • Table 45 Forecast Sales of Digestive Remedies by Category: % Value Growth 2011-2016

Ear Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • In December 2010 Novartis bought the rest of Alcon, Inc. for US$12.9 billion – the largest deal in Swiss corporate history. Alcon’s Orla-Wax is the second-largest ear care product, with a 15% value share. As Novartis’s products generally have higher price points, it is expected that this merger will cause the price of Orla-Wax to increase, boosting value sales slightly.

SWITCHES

COMPETITIVE LANDSCAPE

  • Given the low value of this category, few companies find it attractive to enter, leaving only two relatively large competitors: Wyeth SA de CV’s Auralyt, the leader with a 47% value share at the end of the review period, and Novartis’s Orla-Wax with 15%.

PROSPECTS

  • Novartis might take share from Wyeth, as it is expected to improve its distribution and POS exhibition and increase its medical marketing support.

CATEGORY DATA

  • Table 46 Sales of Ear Care: Value 2006-2011
  • Table 47 Sales of Ear Care: % Value Growth 2006-2011
  • Table 48 Ear Care Company Shares by Value 2007-2011
  • Table 49 Ear Care Brand Shares by Value 2008-2011
  • Table 50 Forecast Sales of Ear Care: Value 2011-2016
  • Table 51 Forecast Sales of Ear Care: % Value Growth 2011-2016

Eye Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • In 2010, Novartis purchased Alcon Laboratories, far and away the leader in eye care in Mexico, from Nestlé. From this purchase, Novartis acquired Naturalag, Solutina, Solutina F, Tears Naturale and Naphtears, making it the pharmaceutical company with one of the largest OTC eye care portfolios in Mexico. The recently-purchased products also include several Rx medications, such as Vigamoxi, Ciloxan and Tobrex based on antibiotics, which fight serious eye infections. Some products (Duotrav, Azopt, and Betoptic) even combat glaucoma.

SWITCHES

COMPETITIVE LANDSCAPE

  • Alcon Laboratorios SA de CV, the leader in eye care in Mexico, was bought by Novartis in 2010. Alcon brands account for a 35% of all eye care sales, driving total Novartis AG sales to reach 43% of the eye care industry.

PROSPECTS

  • Prospects for OTC products in general and for eye care in particular will be highly influenced by demographics in years to come. The population of Mexico, as in many emerging countries, is ageing. Women have also moved from having a large number of offspring to having only two children per woman in a couple of decades. This, combined with increasing life expectancy, will increase demand for more medications and health services. The category of eye care is prone to grow as people aged over 40 begin to take greater care of their eyes.

CATEGORY DATA

  • Table 52 Sales of Eye Care by Category: Value 2006-2011
  • Table 53 Sales of Eye Care by Category: % Value Growth 2006-2011
  • Table 54 Standard Eye Care by Format: % Value Breakdown 2007-2011
  • Table 55 Standard Eye Care by Positioning: % Value Breakdown 2007-2011
  • Table 56 Eye Care Company Shares by Value 2007-2011
  • Table 57 Eye Care Brand Shares by Value 2008-2011
  • Table 58 Forecast Sales of Eye Care by Category: Value 2011-2016
  • Table 59 Forecast Sales of Eye Care by Category: % Value Growth 2011-2016

Herbal/Traditional Products in Mexico - Category Analysis

HEADLINES

TRENDS

  • Herbal/traditional remedies in Mexico have a very long tradition dating back over 1,000 years. A large proportion of herbal remedies consumed in Mexico are produced in artisanally, and distributed via popular markets or tianguis, and are thus very difficult to track. Most Mexicans are aware of these products and believe in their benefits. Many new launches in the dietary supplement category occurred in 2011, including many natural-based products. Also, traditional products in digestive remedies, cold and flu products continued to be supported by marketing, with very good results. Genomma Lab is purchasing traditional old brands and re-launching them becoming a very successful company in Mexico. Many “Miracle Products” in this category were banned for being misleading, and COFEPRIS is applying a zero-tolerance policy against misleading products and advertising.

COMPETITIVE LANDSCAPE

  • Cadbury Adams Mexico accounted for a 31% share of total retail value sales in 2011, given the large acceptance and penetration of medicated confectionery and the presence of its Halls products in Mexico for decades. Medicated confectionery is so widespread in the country that many people consume such products such as sweets, without having any health issues. Herbalife Internacional de México SA de CV was ranked second with 11% of total sales in 2011 due to its Aloe brand. Following on the same medicated confectionery trend, Procter & Gamble de México held third place with a 9% value share through sales of the Vick brand.

PROSPECTS

  • Herbal/traditional products are very successful. The consumer health environment is about trust, which is why traditional brands are expected to maintain and sometimes regain their popularity. Herbal/traditional products are expected to see a constant value CAGR of 2% over forecast period to reach Mx$6.1 billion in 2016.

CATEGORY DATA

  • Table 60 Sales of Herbal/Traditional Products: Value 2006-2011
  • Table 61 Sales of Herbal/Traditional Products: % Value Growth 2006-2011
  • Table 62 Herbal/Traditional Products Company Shares 2007-2011
  • Table 63 Herbal/Traditional Products Brand Shares 2008-2011
  • Table 64 Forecast Sales of Herbal/Traditional Products: Value 2011-2016
  • Table 65 Forecast Sales of Herbal/Traditional Products: % Value Growth 2011-2016

Medicated Skin Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • Diabetes rates are soaring in Mexico due to unhealthy diets and obesity, reaching more than nine million people in 2011 according to the Mexican Diabetes Federation. Due to the wide range of side effects caused by diabetes, the epidemic is impacting many categories in the field of health. One of these side effects is the appearance of skin fungus, driving demand for antifungal products. Some companies, such as local player Genomma Lab, are capitalising on this epidemic, launching several new products in recent years to fight skin fungus.

SWITCHES

COMPETITIVE LANDSCAPE

  • Genomma Lab products led this category at the end of the review period, its share increasing from 14% to 19% over 2010-2011. Its fastest growing products were Medicasp, Unesia, SilkaMedic and Lomecan, all of which were heavily advertised. Genomma Lab invests heavily in advertising, taking advantage of the fact that many Mexicans are swayed by television advertisements. This has allowed it to take share from the largest competitors, Bayer and Schering-Plough, both of which saw declines in share, while Genomma Lab’s sales increased 43%. Schering-Plough SA de CV de Mexico was the second-largest player with a 10% value share, mainly due to its very popular topical anti-fungal Lotrimin.

PROSPECTS

  • Medicated skin care is a somewhat mature category, and yet there are three factors that lead to a promising future. One is demographics due to an ageing population that will demand more OTC skin products in the future for ailments more common in the elderly. Second is the prevalence of diabetes in the country, and its recurrent high levels despite continuous government efforts to lower them. Third is climate change, which has made floods much more frequent (they are not a rare event but an expected annual emergency), which tend to increase fungal infections.

CATEGORY DATA

  • Table 66 Sales of Medicated Skin Care by Category: Value 2006-2011
  • Table 67 Sales of Medicated Skin Care by Category: % Value Growth 2006-2011
  • Table 68 Medicated Skin Care Company Shares by Value 2007-2011
  • Table 69 Medicated Skin Care Brand Shares by Value 2008-2011
  • Table 70 Hair Loss Treatments Brand Shares by Value 2008-2011
  • Table 71 Forecast Sales of Medicated Skin Care by Category: Value 2011-2016
  • Table 72 Forecast Sales of Medicated Skin Care by Category: % Value Growth 2011-2016

NRT Smoking Cessation Aids in Mexico - Category Analysis

HEADLINES

TRENDS

  • In Mexico, for the past decade the tobacco industry has faced a number of drastic reforms that have placed a series of strict regulations aiming to reduce the number of smokers in the country. In 2011 tobacco products faced a series of regulations making it difficult for tobacco to reach consumers; these included: 2008 saw a ban on smoking in public places implemented; tobacco products may not be advertised in any media with the sole exception of print (magazines) with content for adults (such as politics, economy, adult content); tobacco products are located out of reach of consumers and must be provided by sales staff; tobacco products bear high taxation which increased again in 2011; tobacco products must show graphic images regarding the medical dangers of tobacco consumption. However, all these measures have resulted in a moderate rather than a drastic fall in smoking activity among the approximately 14 million smokers in the country. This fact, coupled with the relatively high cost of NRT cessation aids, is why these products demonstrated even a small decrease in sales over the review period.

SWITCHES

COMPETITIVE LANDSCAPE

  • Only two companies, both international players, divide retail sales of NRT smoking cessation aids in Mexico. GlaxoSmithKline led in 2011 holding 34% of total retail sales due to its dominance with Niquitin. Pharmacia & Upjohn was second with 29% of total sales in 2011, offering Nicorette within NRT gum. GlaxoSmithKline dominates NRT patches, holding a 60% value share at the end of the review period.

PROSPECTS

  • It is doubtful that even if the tobacco industry retains its strict regulations that discourage tobacco consumption, demand for NRT smoking cessation aids will increase significantly. In fact, for at least the term of the review period the tobacco industry has been under strict rules and that has had a very limited impact on demand for NRT smoking cessation aids. As the value is low pharmaceutical companies do not regard it as a key product in which to invest. In fact, when Niquitin was launched it received a high level of marketing support, but did not show strong growth despite that investment.

CATEGORY INDICATORS

  • Table 73 Number of Smokers by Gender 2006-2011

CATEGORY DATA

  • Table 74 Sales of NRT Smoking Cessation Aids by Category: Value 2006-2011
  • Table 75 Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2006-2011
  • Table 76 NRT Gum Flavours: % Value Breakdown 2006-2011
  • Table 77 NRT Smoking Cessation Aids Company Shares by Value 2007-2011
  • Table 78 NRT Smoking Cessation Aids Brand Shares by Value 2008-2011
  • Table 79 Forecast Sales of NRT Smoking Cessation Aids by Category: Value 2011-2016
  • Table 80 Forecast Sales of NRT Smoking Cessation Aids by Category: % Value Growth 2011-2016

Sports Nutrition in Mexico - Category Analysis

HEADLINES

TRENDS

  • According to the most recent statistics from the Mexican Ministry of Health, overweight and obesity are becoming an alarming national issue, increasing the incidence of a large number of related diseases such as diabetes mellitus, which already accounted for around 14% of all deaths in the country, followed by cardiovascular diseases (11%) and hypertension (3%). During the review period the government promoted consumption of fresh food as the best measure to combat overweight and obesity, and highlighted the need for regular physical activity, with programmes such as “Actívate, vive mejor” (Exercise, live better). However, as these programmes seem to be unsuccessful the government has been forced to take action, such as requiring a mandatory 30-minute slot every day dedicated to physical activity in all elementary schools and banning the sale of unhealthy food in the surrounding areas of all public schools in the country. The category saw growth of 7% in current value terms in 2011 because the leading players are expanding their consumer base, focusing not only on male body-builders but anyone who engages in physical activity, such as women who practice fitness exercise (aerobics, spinning, etc..), runners, cyclists, and people who practice tae-kwon-do.

COMPETITIVE LANDSCAPE

  • The competitive landscape of sports nutrition in Mexico is led by two domestic companies: Pronat with 22%, followed by Universal Nutrition with 8% and Nutrisa with 7%. ProWinner’s strategy is to give support to Mexican athletes of different disciplines and thus diversify the target. Also, many brands have very good distribution channels (selling products through healthfood shops Nutrisa, Tienda Naturista and hypermarket giant Wal-Mart) and on-pack promotions. Nutrisa leverages its wide number of POS and store reputation. Nutrisa owns aproximately150 stores and there are approximately 56 franchises.

PROSPECTS

  • In the near future it is expected that an increasing number of Mexicans will suffer from overweight and obesity. It is projected that around 44% of the population aged 15 or over will be overweight and another 35% obese in 2020. Given these alarming rates consumers are expected to become more aware of the positive impact of healthy nutrition, sports and physical activities on their health, and thus increase their spending on health and nutritional products, as well as on fitness activities and sports products.

CATEGORY DATA

  • Table 81 Sales of Sports Nutrition: Value 2006-2011
  • Table 82 Sales of Sports Nutrition: % Value Growth 2006-2011
  • Table 83 Sports Nutrition Company Shares 2007-2011
  • Table 84 Sports Nutrition Brand Shares 2008-2011
  • Table 85 Forecast Sales of Sports Nutrition: Value 2011-2016
  • Table 86 Forecast Sales of Sports Nutrition: % Value Growth 2011-2016

Vitamins and Dietary Supplements in Mexico - Category Analysis

HEADLINES

TRENDS

  • Sedentary and busy, stressful lifestyles, combined with poor eating habits, are causing many Mexicans to have an unbalanced diet. For example, Mexicans are among the top five consumers of carbonates in the world and major consumers of packaged food products, which tend to be high in calories, sugars and fats and with limited nutritional value. While this industry remains relatively small in Mexico, it is on the rise due to public health campaigns focusing on improved nutrition and healthy habits. As most Mexicans continue to have unhealthy diets, some health-conscious consumers are seeking to compensate for their poor eating habits through use of vitamins and dietary supplements.

VITAMINS

DIETARY SUPPLEMENTS

COMPETITIVE LANDSCAPE

  • Vitamins and dietary supplements is a highly fragmented category in Mexico, with dozens of small companies operating with an artisanal production range and with only one company, Herbalife, holding over 29% share of total retail value. The company benefits from targeting a wide population base of low- and middle-income consumers, and by having a large number of individual distributors. Herbalife also benefits from holding and maintaining the image of a company that manufactures natural-based products. Herbalife gained five percentage share points in 2011.

PROSPECTS

  • In coming years, vitamins and dietary supplements will be highly influenced by demographic factors. Mexico’s population, as in many emerging countries, is ageing; women also shifted from having a large number of offspring to only two children per woman over a couple of decades. This is combined with increasing life expectancy. The segment of people aged 60 years and over will increase by more than 20% over the forecast period, passing from just under 9% of the total population to 10%. This large increase over just five years will lead to consumers demanding more vitamins and dietary supplements to maintain their health.

CATEGORY DATA

  • Table 87 Sales of Vitamins and Dietary Supplements by Category: Value 2006-2011
  • Table 88 Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2006-2011
  • Table 89 Dietary Supplements by Positioning 2006-2011
  • Table 90 Vitamins and Dietary Supplements Company Shares by Value 2007-2011
  • Table 91 Vitamins and Dietary Supplements Brand Shares by Value 2008-2011
  • Table 92 Vitamins Brand Shares by Value 2008-2011
  • Table 93 Dietary Supplements Brand Shares by Value 2008-2011
  • Table 94 Forecast Sales of Vitamins and Dietary Supplements by Category: Value 2011-2016
  • Table 95 Forecast Sales of Vitamins and Dietary Supplements by Category: % Value Growth 2011-2016

Weight Management in Mexico - Category Analysis

HEADLINES

TRENDS

  • The global obesity epidemic is affecting Mexico much more seriously than most other countries. According to a recent study by the OECD, Mexico has the second-largest obese population after the United States, and thus obesity is officially considered an epidemic. Furthermore, Mexico has the highest proportion of overweight and obese children in the world. According to the IMSS (Instituto Mexicano del Seguro Social – Mexican Social Security Institute), the situation is so severe that it is no longer uncommon to see patients aged 18-30 already suffering from heart attacks due to their obesity, and one in three Mexicans is a candidate for a gastric bypass procedure. While some wealthier segments of the population are more health-conscious, obesity is now spread across all income segments. Sedentary and busy, stressful lifestyles, combined with poor eating habits are causing many Mexicans to become overweight. For example, Mexicans are among the top five consumers of carbonates in the world, and major consumers of packaged foods, which tend to be high in calories, sugars and fats.

COMPETITIVE LANDSCAPE

  • Herbalife leads the category by far with a 41% share, and sales worth Mx$3.7 billion, with an increase of 34% in current value terms compared with 2010. Its success is based on its 25,000 Nutrition Clubs ranging from three to over 70 members each. Herbalife claims an outstanding distribution network of over 400,000 independent distributors, and such a vast network cannot be matched by any other company. All players increased their sales somewhat.

PROSPECTS

  • Over the forecast period it is expected that an increasing number of Mexicans will suffer from overweight and obesity. It is projected that around 44% of the population aged 15 or above will be overweight and another 35% obese in 2020. Given the extremely severe rates of obesity and people being overweight that Mexico suffers from, and the diabetes epidemic, retail sales of weight management products should continue to show positive results. However, this growth will be followed by equally increasing attention from the health authorities, which will continue to ban products and ingredients that prove risky for the health of consumers. COFEPRIS and the Ministry of Health will keep an eye on weight management products in Mexico and continue fining companies that do not comply with legislation.

CATEGORY DATA

  • Table 96 Sales of Weight Management: Value 2006-2011
  • Table 97 Sales of Weight Management: % Value Growth 2006-2011
  • Table 98 Weight Management Company Shares 2007-2011
  • Table 99 Weight Management Brand Shares 2008-2011
  • Table 100 Forecast Sales of Weight Management: Value 2011-2016
  • Table 101 Forecast Sales of Weight Management: % Value Growth 2011-2016

Wound Care in Mexico - Category Analysis

HEADLINES

TRENDS

  • In 2011 wound care grew by 1% in current value terms to reach Mx$242 million. This is a mature category with low rates of new product technologies or delivery formats. The main innovations generally come in the form of new characters on adhesive bandages for children. In 2011 the main innovation was from BDF Curitas with Distroller, an image of the Virgin of Guadalupe. The growth rate of 1% was in line with the previous year due to the lack of aggressive investment in new product development or strong advertising or promotion.

COMPETITIVE LANDSCAPE

  • The category is so small that the top six companies account for almost 90% of total sales. Kendall de México SA de CV is the largest company in the category, holding a 35% value share, due to the fact that Kendall is the only company with an important participation in both sticking plasters and other wound care with a share of 36% in sticking plasters/adhesive bandages and 32% in gauze, tape and other wound care. Ranked second was BDF México SA de CV which held a 16% value share in 2011 due to the success of its Hansaplast brand, which is present only in sticking plasters/adhesive bandages.

PROSPECTS

  • Over the forecast period wound care is expected to see a 1% constant value CAGR to reach Mx$259 million in 2016. The category is guaranteed to see a continued increase as the population continues to grow and age in coming years. The diabetes epidemic that accounted for 10% of the population at the end of the review period will fuel the popularity of these products, a people suffering diabetes have a propensity get foot wounds.

CATEGORY DATA

  • Table 102 Sales of Wound Care by Category: Value 2006-2011
  • Table 103 Sales of Wound Care by Category: % Value Growth 2006-2011
  • Table 104 Wound Care Company Shares by Value 2007-2011
  • Table 105 Wound Care Brand Shares by Value 2008-2011
  • Table 106 Forecast Sales of Wound Care by Category: Value 2011-2016
  • Table 107 Forecast Sales of Wound Care by Category: % Value Growth 2011-2016

Segmentation

Segmentation

This market research report includes the following:

  • Consumer Health

Statistics Included

Statistics Included

For each category and subcategory you will receive the following data in Excel format:

From Passport

  • Market sizes
  • Company shares
  • Brand shares
  • Distribution
  • Analysis by format
  • Analysis by positioning
  • Analysis by type
  • Herbal/traditional vs standard
  • Pricing
  • Smoking population - number of adult smokers
  • Smoking prevalence - % of adult population

Market size details:

  • Retail volume
  • Retail volume % growth
  • Retail volume per capita
  • Retail value retail selling price % growth
  • Retail value retail selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices % growth
  • Retail value retail selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price % growth
  • Retail value manufacturer selling price local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices % growth
  • Retail value manufacturer selling price real (constant 2008) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price real (constant 2008) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices % growth
  • Retail value retail selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value retail selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices % growth
  • Retail value manufacturer selling price nominal (current) prices local currency, USD, EUR, GBP, CHF, JPY
  • Retail value manufacturer selling price nominal (current) prices per capita local currency, USD, EUR, GBP, CHF, JPY

Methodology

Methodology

Global insight and local knowledge

With 40 years’ experience of developed and emerging markets, Euromonitor International’s research method is built on a unique combination of specialist industry knowledge and in-country research expertise.

This approach is what enables us to achieve our goal of building a market consensus view of size, shape and trends across the full distribution universe of each category. We factor in whichever channels are relevant, from large-scale grocery to direct sellers, from discount stores to local mom-and-pop outlets.

Industry specialists

Each industry we cover is managed by an Industry Manager and team of Industry Analysts who research and report on their specialist categories all year round.

Our collaborative approach to research means that these industry teams are in constant dialogue with industry players and opinion formers. The planning of our research programmes reflects latest market trends and industry events. In completing each update project, this provides invaluable input to the testing, review and finalisation of our data.

The specialist in-house teams bring together findings from all stages of the annual research process. They work closely with in-country analysts, assess and challenge data and exercise final editorial control over the publication of new data and analysis.

Country and regional analysts

Our in-country analyst network is managed by country and regional analysts in our offices around the world. Working closely with each in-country team, the regional research management team ensures that all country researchers are well schooled in best practices, from the information collected in store checks, to the dialogue we build in trade surveys. Our country analysts ensure that national reports explain the data trends and provide clear insights into the local market’s dynamics.

In-country research network

To deliver fresh insights every year in countries all around the world, we believe the strongest approach is to use analysts on the ground. They bring fluency in local language, physical proximity to the best sources, an ability to engage directly with local industry contacts, and an awareness of how the products and services we study are advertised, sold and consumed. These are essential parts of our ability to report incisively on these markets.

Research Methodology

Our research methods

Each Euromonitor International industry report is based on a core set of research techniques:

Desk research

With industry events, corporate activity, trends and new product introductions tracked year round by our industry team, desk research provides a starting point for the in-country research programme. Our in-country researchers will access the following sources:

  • National statistics offices governmental and official sources
  • National and international trade press
  • National and international trade associations
  • Industry study groups and other semi-official sources
  • Company financials and annual reports
  • Broker reports
  • Online databases
  • The financial, business and mainstream press

Accessing sources is only the first step. The ability to interpret and reconcile often conflicting information across multiple sources is a key aspect of the added value we provide.

Store checks

Store checks are an integral part of our methods for product industries. Carried out on the ground across a relevant mix of channels, the information gained provides first-hand insights into the products we are researching, specifically:

  • Place: We track products in all relevant channels, selective and mass, store and non-store
  • Product: What are innovations in products, pack sizes and formats?
  • Price: What are brand price variations across channels, how do private label’s prices compare to those of branded goods?
  • Promotion: What are marketing and merchandising trends, offers, discounts and tie-ins?

Findings are cross-referenced with brand share data analysis. The results, combined with the findings of desk research, provide a strong basis for identifying key areas of questioning to take forward into our trade survey.

Trade survey

Interaction with global players at corporate HQ and regional levels is complemented by unique local data and insights from our in-country trade surveys around the world. Through the high profile of the Euromonitor International brand, we are able to talk directly to a wide range of sources and therefore inform our analysis with the knowledge and opinions of the leading operators in the market.

Trade surveys allow us to:

  • Fill gaps in available published data per company
  • Generate a consensus view of the size, structure and strategic direction of the category
  • Access year-in-progress data where published sources are out of date
  • Evaluate the experts’ views on current trends and market developments

In building our composite industry view, we engage with a variety of personnel in key players at all points of the supply chain: materials suppliers, manufacturers, distributors, retailers and service operators. We also interview desk research sources: industry associations; study groups; and third party observers from the trade and financial press.

Our objective is to engage in conversation with trade sources in which we exchange ideas and views on the industry, sharing our work-in-progress findings on supply/demand dynamics and potential. This dialogue enhances both parties’ understanding of the local market. The scope and reach of our trade survey also serves to eliminate bias (intentional and unintentional) from any single source.

Company analysis

At a global level, our company research combines our mix of industry interaction and use of secondary sources such as annual accounts, broker reports, financial press and databases. From a data perspective, the aim is to build “top-down” estimates of major players’ total global and regional sales.

At a country level, in line with local reporting requirements, we access annual accounts, national-specific company databases and local company websites. These are all invaluable sources as we build a view of each domestic player’s size and position within very specific categories of the industry.

Forecasts

Data projections and future performance analysis are key elements of Euromonitor International’s market intelligence. Working with historic trends of 15 years or more, a key aspect of our trade survey is to engage industry insider views of the next five years. Will volumes maintain their historic trend? Will price increases or falls of recent years continue, accelerate or slow down? Will increasing demand for one product cannibalise sales of another?

Forecasts represent many of the essential conclusions we have reached about the current state of the market, how it works and how it behaves under different macro and micro conditions. Our written analysis will state the assumptions and the trade opinion behind whether our predictions are optimistic or pessimistic, so that clients can use our statistical forecasts with confidence.

Data validation

All data is subjected to an exhaustive review process, at country, regional and global levels.

The interpretation and review of sources and data inputs forms a central part of the collaboration between industry teams and country researchers. Numbers are delivered to regional and global offices with an audit trail of sources and calculations to allow for a thorough evaluation of data sense and integrity.

Upon completion of the country review phase, data is then reviewed on a comparative basis at regional and then at a global level. Comparative checks are carried out on per capita consumption and spending levels, growth rates, patterns of category and subcategory breakdowns and distribution of sales by channel. Top-down estimates are reviewed against bottom-up regional and global market and company sales totals.

Where marked differences are seen between proximate country markets or ones at similar developmental levels, supplementary research is conducted in the relevant countries to confirm and/or amend those findings. This process ensures international comparability across the database, that consistent category and subcategory definitions have been used and that all data has been correctly tested. We make sure that possible discrepancies between different published sources have been reconciled and that our interpretation of opinion and expectation from each country’s trade sources has been applied to form a coherent international pattern.

Market analysis

Another integral part of all our research programmes is that all Euromonitor International data is accompanied by clear written analysis. From a research perspective, this explains and substantiates data findings. From a client perspective, this offers unique insights into local consumption trends, routes to market, brand preferences, channel dynamics and future trends.

Our country level analysis also provides invaluable input into the ability of our central industry specialist teams to marry local insights with strategic conclusions on the direction of the market regionally and globally.

my pages

Want to find out more about this report?

If you purchase a report that is updated in the next 60 days, we will send you the new edition of the report and the data extract FREE!